Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04517799Phase 2Active, not recruiting
A Phase 2 trial of cannabidiol in Autism Spectrum Disorder (ASD), sponsored by University of California, San Diego. Started Jun 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04517799.